Stocks
Nektar Therapeutics (NKTR) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 5 631% | 2 670% | 3 846% | 3 846% | 12 865% | 9 800% | |||
| Changes by years, y/y, % | +3 977pp | -2 960pp | +1 176pp | 0pp | +9 019pp | +35.6% | |||
Nektar Therapeutics. R&D/CAPEX, %
Nektar Therapeutics. R&D/CAPEX, changes, pp
Nektar Therapeutics (NKTR) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 72 939% | 12 634% | 17 457% | 15 981% | 5 260% | 9 800% | ||
| Changes by years, y/y, % | +54 381pp | +5 849pp | +10 421pp | -2 341pp | -67 679pp | |||
| Changes by quarters, q/q, % | +54 618pp | -60 306pp | +4 824pp | -1 477pp | -10 721pp | |||
